Impressions from Viewpoint Biotech 2025

Yesterday, BioRegio STERN Management GmbH, together with LBBW Venture Capital GmbH, once again invited to Viewpoint Biotech 2025 in Tübingen. Start-ups, entrepreneurs, and industry experts came together to exchange ideas about current developments, challenges, and perspectives in biotechnology.

A-20250605_BioTech_019.jpg

Von links nach rechts: Dr. Frank Mühlenbeck, Prof. Dr. Manfred Claassen, Dr. Julia Schüler, Lena Schober, Dr. Björn Tränkle, Dr. Klaus Eichenberg

/
Copyright: Max Kovalenko/BioRegio STERN Management GmbH

The auditing firm EY presented current data and analyses on the state of the German biotechnology sector. The focus was on how the full potential of the industry can be realized in the future — especially considering geopolitical developments and new partnership models.

A high-profile panel discussion featured Dr. Julia Schüler (BIO. ASPEKTE), Dr. Björn Tränkle (immuneAdvice GmbH), Prof. Dr. Manfred Claassen (Vicinity Bio GmbH), and Lena Schober (KyooBe Tech GmbH), who debated key industry viewpoints. The discussion offered exciting insights from diverse perspectives — ranging from start-ups and SMEs to research and investment.

Cover Flyer standpunkt Biotech 2025.PNG

Here you can review the key information about the event once again (in german).

Logoband SP Biotech 2025.png
Source:
BioRegio STERN Management GmbH